NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway

Cancer Biology and Therapy

Volumn 17, Issue 9, 2016, Pages 943-954

  Ai, Runna ^a   Sun, Yulin ^a   Guo, Zhimin ^a   Wei, Wei ^b   Zhou, Lanping ^a   Liu, Fang ^a   Hendricks, Denver T ^b   Xu, Yang ^a   Zhao, Xiaohang ^a  

^a CANCER HOSPITAL   (China)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

EMT; esophageal cancer; NDRG1; TLE2; Wnt pathway; catenin

Indexed keywords

ANGIOPOIETIN 1; BETA CATENIN; CYTOPLASM PROTEIN; GELATINASE A; INTERSTITIAL COLLAGENASE; KI 67 ANTIGEN; LENTIVIRUS VECTOR; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MYC PROTEIN; N MYC DOWN REGULATED GENE 1 PROTEIN; NERVE CELL ADHESION MOLECULE; OSTEOPONTIN; PROTEIN KINASE SYK; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSDUCIN; TRANSDUCIN LIKE ENHANCER OF SPLIT 2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; WNT3A PROTEIN; WNT5A PROTEIN; CELL CYCLE PROTEIN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; SIGNAL PEPTIDE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LENTIVIRINAE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR XENOGRAFT; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; BIOSYNTHESIS; DISEASE EXACERBATION; ESOPHAGUS TUMOR; GENETICS; METABOLISM; NUDE MOUSE; ONCOGENE MYC; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WNT SIGNALING; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, MYC; HETEROGRAFTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; TRANSFECTION; WNT SIGNALING PATHWAY;

EID: 84983293002     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2016.1210734     Document Type: Article

References (47)

1. W.Wei, J.C.Bracher-Manecke, X.Zhao, N.H.Davies, L.Zhou, R.Ai, L.Oliver, F.Vallette, D.T.Hendricks. Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma. Cancer Biol Ther 2013; 14:164-74; PMID:23192272; http://dx.doi.org/10.4161/cbt.22956
2. N.K.Botelho, F.I.Schneiders, S.J.Lord, A.K.Freeman, S.Tyagi, D.J.Nancarrow, N.K.Hayward, D.C.Whiteman, R.V.Lord. Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues. Cancer Biol Ther 2010; 10:172-9; PMID:20543560; http://dx.doi.org/10.4161/cbt.10.2.12166
3. J.Li, J.Ying, Y.Fan, L.Wu, Y.Ying, A.T.Chan, G.Srivastava, Q.Tao. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol Ther 2010; 10:617-24; PMID:20603606; http://dx.doi.org/10.4161/cbt.10.6.12609
4. M.Jain, S.Kumar, R.Upadhyay, P.Lal, A.Tiwari, U.C.Ghoshal, B.Mittal. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome:an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther 2007; 6:1553-8; PMID:17912028; http://dx.doi.org/10.4161/cbt.6.10.4709
5. J.Sun, D.Zhang, D.H.Bae, S.Sahni, P.Jansson, Y.Zheng, Q.Zhao, F.Yue, M.Zheng, Z.Kovacevic, et al. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors. Carcinogenesis 2013; 34:1943-54; PMID:23671130; http://dx.doi.org/10.1093/carcin/bgt163
6. P.Lachat, P.Shaw, S.Gebhard, N.van Belzen, P.Chaubert, F.T.Bosman. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 2002; 118:399-408; PMID:12432451; http://dx.doi.org/10.1007/s00418-002-0460-9
7. H.Wang, H.Qian, J.Yu, X.Zhang, L.Zhang, M.Fu, X.Liang, Q.Zhan, C.Lin. Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs. Cancer Biol Ther 2006; 5:380-5; PMID:16481741; http://dx.doi.org/10.4161/cbt.5.4.2477
8. M.Takaoka, S.H.Kim, T.Okawa, C.Z.Michaylira, D.B.Stairs, C.N.Johnstone, C.D.Andl, B.Rhoades, J.J.Lee, A.J.Klein-Szanto, et al. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biol Ther 2007; 6:534-40; PMID:17457048; http://dx.doi.org/10.4161/cbt.6.4.3832
9. Y.Wang, H.Zhu, L.Quan, C.Zhou, J.Bai, G.Zhang, Q.Zhan, N.Xu. Downregulation of survivin by RNAi inhibits the growth of esophageal carcinoma cells. Cancer Biol Ther 2005; 4:974-8; PMID:16082195; http://dx.doi.org/10.4161/cbt.4.9.1914
10. Y.Yang, B.G.Goldstein, H.H.Chao, J.P.Katz. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 2005; 4:1216-21; PMID:16357509; http://dx.doi.org/10.4161/cbt.4.11.2090
11. B.A.Fang, Z.Kovacevic, K.C.Park, D.S.Kalinowski, P.J.Jansson, D.J.Lane, S.Sahni, D.R.Richardson. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochim Biophys Acta 2014; 1845:1-19; PMID:24269900; http://dx.doi.org/10.1016/j.bbagrm.2013.11.001
12. X.Chang, X.Xu, J.Ma, X.Xue, Z.Li, P.Deng, S.Zhang, Y.Zhi, J.Chen, D.Dai. NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells. Mol Biol Rep 2014; 41:6215-23; PMID:24985974; http://dx.doi.org/10.1007/s11033-014-3501-2
13. J.Chen, S.Li, Z.Yang, G.Lu, H.Hu. Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Cancer Sci 2008; 99:706-10; PMID:18377423; http://dx.doi.org/10.1111/j.1349-7006.2008.00749.x
14. Z.Mao, J.Sun, B.Feng, J.Ma, L.Zang, F.Dong, D.Zhang, M.Zheng. The metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer. PLoS One 2013; 8:e68206; PMID:23874544; http://dx.doi.org/10.1371/journal.pone.0068206
15. E.Matsuzaki, S.Hiratsuka, T.Hamachi, F.Takahashi-Yanaga, Y.Hashimoto, K.Higashi, M.Kobayashi, T.Hirofuji, M.Hirata, K.Maeda. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. Bone 2013; 55:315-24; PMID:23612487; http://dx.doi.org/10.1016/j.bone.2013.04.008
16. B.Strzelczyk, A.Szulc, R.Rzepko, A.Kitowska, J.Skokowski, A.Szutowicz, T.Pawelczyk. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol 2009; 16:1287-94; PMID:19259744; http://dx.doi.org/10.1245/s10434-009-0381-0
17. W.J.Lu, M.S.Chua, S.K.So. Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis 2014; 35:915-22; PMID:24302615; http://dx.doi.org/10.1093/carcin/bgt401
18. J.C.Lee, L.C.Chung, Y.J.Chen, T.H.Feng, H.H.Juang. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Cancer Lett 2014; 355:242-52; PMID:25218595; http://dx.doi.org/10.1016/j.canlet.2014.08.035
19. M.Dos Santos, A.M.da Cunha Mercante, F.D.Nunes, A.M.Leopoldino, M.B.de Carvalho, D.Gazito, R.V.Lopez, P.B.Chiappini, P.B.de Carvalho Neto, E.E.Fukuyama, et al. Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma. Mol Biol Rep 2012; 39:10157-65; PMID:22972152; http://dx.doi.org/10.1007/s11033-012-1889-0
20. S.Nishio, K.Ushijima, N.Tsuda, S.Takemoto, K.Kawano, T.Yamaguchi, N.Nishida, T.Kakuma, H.Tsuda, T.Kasamatsu, et al. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 2008; 264:36-43; PMID:18281151; http://dx.doi.org/10.1016/j.canlet.2008.01.020
21. S.Sibold, V.Roh, A.Keogh, P.Studer, C.Tiffon, E.Angst, S.A.Vorburger, R.Weimann, D.Candinas, D.Stroka. Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett 2007; 581:989-94; PMID:17316623; http://dx.doi.org/10.1016/j.febslet.2007.01.080
22. T.Ando, H.Ishiguro, M.Kimura, A.Mitsui, H.Kurehara, N.Sugito, K.Tomoda, R.Mori, N.Takashima, R.Ogawa, et al. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 2006; 19:454-8; PMID:17069588; http://dx.doi.org/10.1111/j.1442-2050.2006.00618.x
23. A.J.Symes, M.Eilertsen, M.Millar, J.Nariculam, A.Freeman, M.Notara, M.R.Feneley, H.R.Patel, J.R.Masters, A.Ahmed. Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue. PLoS One 2013; 8:e84295; PMID:24386364; http://dx.doi.org/10.1371/journal.pone.0084295
24. D.Wang, X.Tian, Y.Jiang. NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients. J Cancer Res Clin Oncol 2012; 138:1813-20; PMID:22722710; http://dx.doi.org/10.1007/s00432-012-1236-9
25. M.Sohda, Y.Mochida, H.Kato, T.Miyazaki, M.Nakajima, M.Fukuchi, R.Manda, Y.Fukai, N.Masuda, M.Ono, et al. Overexpression of Cap43 is associated with malignant status of esophageal cancer. Anticancer Res 2009; 29:965-70; PMID:19414333
26. H.Ureshino, Y.Murakami, K.Watari, H.Izumi, A.Kawahara, M.Kage, T.Arao, K.Nishio, K.Yanagihara, H.Kinoshita, et al. N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition. PLoS One 2012; 7:e41312; PMID:22844455; http://dx.doi.org/10.1371/journal.pone.0041312
27. Y.Shimada, M.Imamura, T.Wagata, N.Yamaguchi, T.Tobe. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992; 69:277-84; PMID:1728357; http://dx.doi.org/10.1002/1097-0142(19920115)69:2%3c277::AID-CNCR2820690202%3e3.0.CO;2-C
28. Y.Xu, L.Zhou, J.Huang, F.Liu, J.Yu, Q.Zhan, L.Zhang, X.Zhao. Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma. Clin Cancer Res 2011; 17:5412-22; PMID:21676925; http://dx.doi.org/10.1158/1078-0432.CCR-11-0426
29. S.He, L.Wang, L.Miao, T.Wang, F.Du, L.Zhao, X.Wang. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 2009; 137:1100-11; PMID:19524512; http://dx.doi.org/10.1016/j.cell.2009.05.021
30. X.P.Hao, T.G.Pretlow, J.S.Rao, T.P.Pretlow. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 2001; 61:8085-8; PMID:11719432
31. S.Roy, D.Chakravarty, V.Cortez, K.De Mukhopadhyay, A.Bandyopadhyay, J.M.Ahn, G.V.Raj, R.R.Tekmal, L.Sun, R.K.Vadlamudi. Significance of PELP1 in ER-negative breast cancer metastasis. Mol Cancer Res 2012; 10:25-33; PMID:22086908; http://dx.doi.org/10.1158/1541-7786.MCR-11-0456
32. Y.Xu, Z.Lin, N.Zhao, L.Zhou, F.Liu, Z.Cichacz, L.Zhang, Q.Zhan, X.Zhao. Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells. PLoS One 2014 Jun 24; 9(6):e100127; PMID:24959694; http://dx.doi.org/10.1371/journal.pone.0100127
33. B.Han, W.Li, Y.Sun, L.Zhou, Y.Xu, X.Zhao. A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells via up-regulation of BNIP3 and N-myc downstream-regulated gene-1. PLoS One 2014; 9:e107204; PMID:25232961; http://dx.doi.org/10.1371/journal.pone.0107204
34. M.D.Wissing, J.Mendonca, E.Kim, J.S.Shim, N.S.Kaelber, H.Kant, H.Hammers, T.Commes, P.J.Van Diest, J.O.Liu, et al. Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells. Cancer Biol Ther 2013; 14:401-10; PMID:23377825; http://dx.doi.org/10.4161/cbt.23759
35. H.Clevers, R.Nusse. Wnt/β-catenin signaling and disease. Cell 2012; 149:1192-205; PMID:22682243; http://dx.doi.org/10.1016/j.cell.2012.05.012
36. B.Chen, P.G.Zaveri, M.S.Longtine, D.M.Nelson. N-myc downstream-regulated gene 1 (NDRG1) mediates pomegranate juice protection from apoptosis in hypoxic BeWo cells but not in primary human trophoblasts. Placenta 2015; 36:847-53; PMID:26028238; http://dx.doi.org/10.1016/j.placenta.2015.05.009
37. Z.Chen, D.Zhang, F.Yue, M.Zheng, Z.Kovacevic, D.R.Richardson. The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem 2012; 287:17016-28; PMID:22453918; http://dx.doi.org/10.1074/jbc.M112.350470
38. W.Liu, M.Iiizumi-Gairani, H.Okuda, A.Kobayashi, M.Watabe, S.K.Pai, P.R.Pandey, F.Xing, K.Fukuda, V.Modur, et al. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer. J Biol Chem 2011; 286:18949-59; PMID:21454613; http://dx.doi.org/10.1074/jbc.M111.232637
39. L.R.Pearce, E.M.Sommer, K.Sakamoto, S.Wullschleger, D.R.Alessi. Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem J 2011; 436:169-79; PMID:21413931; http://dx.doi.org/10.1042/BJ20102103
40. B.T.MacDonald, K.Tamai, X.He. Wnt/β-catenin signaling:components, mechanisms, and diseases. Dev Cell 2009; 17:9-26; PMID:19619488; http://dx.doi.org/10.1016/j.devcel.2009.06.016
41. W.Liu, F.Xing, M.Iiizumi-Gairani, H.Okuda, M.Watabe, S.K.Pai, P.R.Pandey, S.Hirota, A.Kobayashi, Y.Y.Mo, et al. N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol Med 2012; 4:93-108; PMID:22246988; http://dx.doi.org/10.1002/emmm.201100190
42. R.Jin, W.Liu, S.Menezes, F.Yue, M.Zheng, Z.Kovacevic, D.R.Richardson. The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4. J Cell Sci 2014; 127:3116-30; PMID:24829151; http://dx.doi.org/10.1242/jcs.147835
43. V.Melotte, X.Qu, M.Ongenaert, W.van Criekinge, A.P.de Bruine, H.S.Baldwin, M.van Engeland. The N-myc downstream regulated gene (NDRG) family:diverse functions, multiple applications. FASEB J 2010; 24:4153-66; PMID:20667976; http://dx.doi.org/10.1096/fj.09-151464
44. A.J.Hanson, H.A.Wallace, T.J.Freeman, R.D.Beauchamp, L.A.Lee, E.Lee. XIAP monoubiquitylates Groucho/TLE to promote canonical Wnt signaling. Mol Cell 2012; 45:619-28; PMID:22304967; http://dx.doi.org/10.1016/j.molcel.2011.12.032
45. M.Buscarlet, A.Perin, A.Laing, J.M.Brickman, S.Stifani. Inhibition of cortical neuron differentiation by Groucho/TLE1 requires interaction with WRPW, but not Eh1, repressor peptides. J Biol Chem 2008; 283:24881-8; PMID:18611861; http://dx.doi.org/10.1074/jbc.M800722200
46. M.Roth, B.Bonev, J.Lindsay, R.Lea, N.Panagiotaki, C.Houart, N.Papalopulu. FoxG1 and TLE2 act cooperatively to regulate ventral telencephalon formation. Development 2010; 137:1553-62; PMID:20356955; http://dx.doi.org/10.1242/dev.044909
47. Z.He, Y.Liu, D.Liang, Z.Wang, E.S.Robertson, K.Lan. Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus. J Virol 2010; 84:2047-62; PMID:19939918; http://dx.doi.org/10.1128/JVI.01984-09